These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 23877317)

  • 1. TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells.
    Fu J; Yang QY; Sai K; Chen FR; Pang JC; Ng HK; Kwan AL; Chen ZP
    Neuro Oncol; 2013 Oct; 15(10):1353-65. PubMed ID: 23877317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTK7 regulates Id1 expression in CD44-high glioma cells.
    Liu Q; Zhang C; Yuan J; Fu J; Wu M; Su J; Wang X; Yuan X; Jiang W
    Neuro Oncol; 2015 Apr; 17(4):505-15. PubMed ID: 25204555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling.
    Yin J; Oh YT; Kim JY; Kim SS; Choi E; Kim TH; Hong JH; Chang N; Cho HJ; Sa JK; Kim JC; Kwon HJ; Park S; Lin W; Nakano I; Gwak HS; Yoo H; Lee SH; Lee J; Kim JH; Kim SY; Nam DH; Park MJ; Park JB
    Cancer Res; 2017 Sep; 77(18):4973-4984. PubMed ID: 28754668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance.
    Tran AN; Walker K; Harrison DG; Chen W; Mobley J; Hocevar L; Hackney JR; Sedaka RS; Pollock JS; Goldberg MS; Hambardzumyan D; Cooper SJ; Gillespie Y; Hjelmeland AB
    Neuro Oncol; 2018 Jul; 20(8):1055-1067. PubMed ID: 29409010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transglutaminase 2 gene is aberrantly hypermethylated in glioma.
    Dyer LM; Schooler KP; Ai L; Klop C; Qiu J; Robertson KD; Brown KD
    J Neurooncol; 2011 Feb; 101(3):429-40. PubMed ID: 20596752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cancer stem cells through L1CAM suppresses glioma growth.
    Bao S; Wu Q; Li Z; Sathornsumetee S; Wang H; McLendon RE; Hjelmeland AB; Rich JN
    Cancer Res; 2008 Aug; 68(15):6043-8. PubMed ID: 18676824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RETRACTED: CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance.
    Yoon C; Park DJ; Schmidt B; Thomas NJ; Lee HJ; Kim TS; Janjigian YY; Cohen DJ; Yoon SS
    Clin Cancer Res; 2014 Aug; 20(15):3974-88. PubMed ID: 24947926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. uPAR and cathepsin B inhibition enhanced radiation-induced apoptosis in gliomainitiating cells.
    Malla RR; Gopinath S; Alapati K; Gorantla B; Gondi CS; Rao JS
    Neuro Oncol; 2012 Jun; 14(6):745-60. PubMed ID: 22573309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ID1-BMPR2 Intrinsic Signaling Sensitizes Glioma Stem Cells to Differentiation Therapy.
    Jin X; Jin X; Kim LJY; Dixit D; Jeon HY; Kim EJ; Kim JK; Lee SY; Yin J; Rich JN; Kim H
    Clin Cancer Res; 2018 Jan; 24(2):383-394. PubMed ID: 29208670
    [No Abstract]   [Full Text] [Related]  

  • 10. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
    Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
    FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastasis tumor-associated protein-2 knockdown suppresses the proliferation and invasion of human glioma cells in vitro and in vivo.
    Cheng CY; Chou YE; Ko CP; Yang SF; Hsieh SC; Lin CL; Hsieh YH; Chen KC
    J Neurooncol; 2014 Nov; 120(2):273-81. PubMed ID: 25048531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells.
    Johansson E; Grassi ES; Pantazopoulou V; Tong B; Lindgren D; Berg TJ; Pietras EJ; Axelson H; Pietras A
    Cell Rep; 2017 Aug; 20(7):1641-1653. PubMed ID: 28813675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.
    Sullivan KE; Rojas K; Cerione RA; Nakano I; Wilson KF
    Oncotarget; 2017 Apr; 8(14):22325-22343. PubMed ID: 28423611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance.
    Yang W; Wei J; Guo T; Shen Y; Liu F
    Exp Cell Res; 2014 Aug; 326(1):22-35. PubMed ID: 24930954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Irradiated Brain Microenvironment Supports Glioma Stemness and Survival via Astrocyte-Derived Transglutaminase 2.
    Berg TJ; Marques C; Pantazopoulou V; Johansson E; von Stedingk K; Lindgren D; Jeannot P; Pietras EJ; Bergström T; Swartling FJ; Governa V; Bengzon J; Belting M; Axelson H; Squatrito M; Pietras A
    Cancer Res; 2021 Apr; 81(8):2101-2115. PubMed ID: 33483373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling.
    Wang F; Wang L; Qu C; Chen L; Geng Y; Cheng C; Yu S; Wang D; Yang L; Meng Z; Chen Z
    BMC Cancer; 2021 Apr; 21(1):396. PubMed ID: 33845796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentivirus-mediated silencing of HSDL2 suppresses cell proliferation in human gliomas.
    Ruokun C; Yake X; Fengdong Y; Xinting W; Laijun S; Xianzhi L
    Tumour Biol; 2016 Nov; 37(11):15065-15077. PubMed ID: 27658777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth.
    Pietras A; Katz AM; Ekström EJ; Wee B; Halliday JJ; Pitter KL; Werbeck JL; Amankulor NM; Huse JT; Holland EC
    Cell Stem Cell; 2014 Mar; 14(3):357-69. PubMed ID: 24607407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of septin 7 suppresses glioma cell growth.
    Jia ZF; Huang Q; Kang CS; Yang WD; Wang GX; Yu SZ; Jiang H; Pu PY
    J Neurooncol; 2010 Jul; 98(3):329-40. PubMed ID: 20035367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
    Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
    Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.